These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Health consequences of visceral obesity. Després JP Ann Med; 2001 Nov; 33(8):534-41. PubMed ID: 11730160 [TBL] [Abstract][Full Text] [Related]
11. Dyslipidaemia and obesity. Després JP Baillieres Clin Endocrinol Metab; 1994 Jul; 8(3):629-60. PubMed ID: 7980350 [TBL] [Abstract][Full Text] [Related]
12. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863 [TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Chan DC; Barrett HP; Watts GF Am J Cardiovasc Drugs; 2004; 4(4):227-46. PubMed ID: 15285698 [TBL] [Abstract][Full Text] [Related]
14. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Kobayashi H; Nakamura T; Miyaoka K; Nishida M; Funahashi T; Yamashita S; Matsuzawa Y Jpn Circ J; 2001 Mar; 65(3):193-9. PubMed ID: 11266194 [TBL] [Abstract][Full Text] [Related]
15. [Risk factors associated with obesity: a metabolic perspective]. Després JP; Pascot A; Lemieux I Ann Endocrinol (Paris); 2000 Dec; 61 Suppl 6():31-38. PubMed ID: 11148334 [TBL] [Abstract][Full Text] [Related]
16. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
17. Impact of obesity in primary hyperlipidemias. Carmena R; Ascaso JF; Real JT Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and lipid metabolism. Howard BV Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856 [TBL] [Abstract][Full Text] [Related]
19. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men. Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978 [TBL] [Abstract][Full Text] [Related]
20. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Després JP Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095 [No Abstract] [Full Text] [Related] [Next] [New Search]